Saliladja, Jay W.

HRN: 25-51-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/17/2024
07/17/2024
IV INFUSION
600mg
Q8H
SEPTIC SHOCK PROB SEC TO RUPTURED TOPHI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: